Phase Ib Open Clinical Trial to Assess the Safety of Autologous Mesenchymal Stem Cells for the Treatment of Nonrevascularizable Critical Lower Limb Ischemia

Riera Del Moral L^1,2*, Salazar Álvarez A¹, Stefanov Kiuri S¹, Tong H^3,4, Riera De Cubas L¹, García-Olmo D^2,5 and García-Arranz M^2,6

¹Department of Angiology and Vascular Surgery, La Paz University Hospital, Spain

²Department of Surgery, School of Medicine, Autonomous University of Madrid, Spain

³Department of Clinical Pharmacology, La Paz University Hospital, Spain

⁴Department of Ministry of Economy and Competitiveness, Platform for Clinical Research and Clinical Trial Units (SCReN), Spain

⁵Department of General and Digestive Surgery, Fundación Jiménez Díaz, Spain

⁶Laboratory of New Therapies, Fundación Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Spain

^*Corresponding Author: